Drug General Information
Drug ID
D0B3WF
Former ID
DNC001529
Drug Name
YVAD
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534926]
Structure
Download
2D MOL

3D MOL

Formula
C23H31ClN4O8
Canonical SMILES
CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)CCl)NC(=O)C(C1=CC<br />=C(C=C1)O)NC(=O)C
InChI
1S/C23H31ClN4O8/c1-11(2)19(28-23(36)20(26-13(4)29)14-5-7-15(30)8-6-14)22(35)25-12(3)21(34)27-16(9-18(32)33)17(31)10-24/h5-8,11-12,16,19-20,30H,9-10H2,1-4H3,(H,25,35)(H,26,29)(H,27,34)(H,28,36)(H,32,33)/t12-,16-,19?,20-/m0/s1
InChIKey
NZFJKTKBVZFJPT-MFDXPFQTSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Interleukin-1 beta convertase Target Info Inhibitor [534926]
KEGG Pathway NOD-like receptor signaling pathway
Cytosolic DNA-sensing pathway
Amyotrophic lateral sclerosis (ALS)
Salmonella infection
Pertussis
Legionellosis
Influenza A
NetPath Pathway TCR Signaling Pathway
IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
Pathway Interaction Database IL1-mediated signaling events
Direct p53 effectors
IFN-gamma pathway
Cellular roles of Anthrax toxin
Reactome NOD1/2 Signaling Pathway
Interleukin-1 processing
The NLRP3 inflammasome
WikiPathways MAPK Signaling Pathway
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
Apoptosis
Amyotrophic lateral sclerosis (ALS)
Parkin-Ubiquitin Proteasomal System pathway
Interleukin-1 processing
Apoptosis Modulation and Signaling
NOD pathway
References
Ref 534926Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide. Am J Physiol. 1999 Nov;277(5 Pt 2):R1435-43.
Ref 534926Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide. Am J Physiol. 1999 Nov;277(5 Pt 2):R1435-43.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.